Skip to main content
. 2008 Jul 16;3(7):e2661. doi: 10.1371/journal.pone.0002661

Table 2. Variables that vary between scenarios**.

Variable Description Levels
Intensity of transmission Infected bites per adult per year prior to the introduction of IPTi High transmission: 200
Moderate transmission: 100
Reference: 21
Low transmission: 6
Treatment coverage Proportion of malaria fevers treated 4%, 30%
Drug resistance Frequency of 3 different genotypes 100%, 0%, 0%
80%, 10%, 10%
20%, 40%, 40%
0%, 0%, 100%
Prophylactic period Time in days that drug clears blood-stage infections for each of the 3 different genotypes 0,0,0 days (treatment only)
50, 10, 0 days (corresponds to SP)
100, 20, 0 days
IPTi schedule Age at doses 3, 4 and 9 months
Single doses 1.5–24 months*
IPTi coverage Proportion of eligible infants receiving all 3 IPTi doses (coverage with first, second and third dose) 89% (95%,95%,99%)
50% (79%,79%,79%)
100% (100%,100%,100%)
**

One variable was varied at a time. In each scenario, the variables not being evaluated were fixed at the reference levels (indicated in bold).

The seasonality follows that of Namawala, Tanzania.[68] Each simulation assumes a recurring pattern of the vectoral capacity.

The proportion of infections cleared by the genotypes are set at 100%,100% and 50%.

*

We investigated the effect of age at dose by simulating a single IPTi dose at varying ages.